Our initial search on September 20, 2023, identified 4,956 potentially relevant records across all databases (Fig. 1). After deduplication using Endnote and Rayyan, we retained 2,630 records. Of these, 256 passed the title and abstract screening, and 62 went on to pass full-text screening and were included in the systematic review [24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85]. On September 9, 2024, we conducted a rerun and identified 845 potentially new relevant records across the same databases (Fig. 1). A total of 546 records remained after deduplication. Screening by title and abstract led to 35 eligible papers, of which 13 passed full-text screening and were included in the systematic review [86,87,88,89,90,91,92,93,94,95,96,97,98]. This brought the total number of included records to 75 [24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98]. We contacted the corresponding authors of 36 studies via email to request missing data. Of these, six responded: three provided additional data, while the other three were unable to do so. Finally, a total of 16 studies was suitable for meta-analysis [30, 32, 33, 47, 51, 58,